A global medication shortage is affecting at least half a million patients, with 323 drugs in shortage in early 2024.

The shortage affects various drug classes, including chemotherapy, stimulants, antimicrobials, hormones, and intravenous fluids.

Most drug shortages, which last over two years on average, are caused by manufacturing and quality problems.

Lack of transparency in the pharmaceutical industry hinders responses to drug shortages.

The US FDA tracks drug shortages and provides real-time information on their website.

Patients can consult pharmacists or healthcare professionals for information on medication shortages.

The Ministry of Health and Welfare has set up a drug supply notification center to provide real-time information on medication shortages.

The Drug Deficiency Database tracks drug shortages, informing patients and caregivers about medication shortages.

Healthcare systems and pharmacists can manage medication shortages by prioritizing treatment and offering alternative therapies.

Healthcare providers and pharmacists must work together to minimize drug interactions and ensure safe medicine use.

Check the current shortage status of your parent's medications to see if they're affected by global shortages.

You can use online resources like the FDA website to stay informed about medication shortages and find alternatives.

You can consult with your parent's healthcare provider or pharmacist to discuss alternatives and manage their medication regimen during a shortage.

Drug shortages are mainly caused by manufacturing and quality issues, high demand, and currently affect 32 chemotherapy drugs.

Lack of transparency in the pharmaceutical supply chain hinders addressing drug shortages and patient access to needed medications.

The US government has proposed $3.26-5.11 billion to address shortages, and the FDA seeks more power.

A generic drug price increase may alleviate shortages by attracting more manufacturers.

Most treatment shortages last over two years, affecting at least half a million patients.

If your parent takes Amoxicillin, Adderall, or Methylphenidate, they may be affected by the global medication shortages.

You can use online resources like the Tomny app or CharmHealth platform for real-time medication availability and alternative treatments.

These resources provide information on approved drug alternatives and accept inquiries and complaints.

Consult with your parent's healthcare provider or pharmacist to discuss alternatives and manage their medication regimen during a shortage.

Patients may need to renew their residency or explore alternative options to access necessary medications.

The World Health Organization (WHO) supports healthcare and provides funding for life-saving treatments in countries like Syria.

Medication shortages require a multifaceted approach, including support for patients with chronic life-threatening conditions.

To prepare for future shortages, stay informed, consult with your parent's healthcare provider or pharmacist, and explore online resources.

Consider reaching out to patient support groups or advocacy organizations for guidance.

You can encourage your parent's healthcare provider to report medication shortages to the FDA.

By working with healthcare providers and support groups, you can help your parent receive necessary care during a medication shortage.

References:

The US had a record 323 drug shortages by 2024.

France reported 4,925 drug shortages in 2023, affecting 44% of the population by 2024.

The European Union announced pharmaceutical industry reform measures.

In the US, 111 drugs were out of stock in 2021, with the FDA monitoring the supply chain for shortages.

A global shortage of antibiotics has occurred, with 28 of 35 countries lacking penicillin-type drugs.

In 2024, US drug shortages reached 323, exceeding the 2014 record of 320.

[7] Ireland suffered a paracetamol shortage in 2023 due to Covid-19 and flu cases, with medicine shortages increasing worldwide over the past decade.

A survey found 99% of hospital pharmacists report drug shortages, with 309 drugs affected, near an all-time high.

The US had 323 medical drug shortages in 2021, surpassing the previous record of 320 in 2014.

Amoxicillin is in short supply, with 66% of US pharmacies unable to obtain it due to supply chain issues.

The dollar crisis in Egypt has caused a shortage of medicines due to a lack of hard currency.

The coronavirus epidemic has caused drug shortages in Malaysia, worsened by a weak ringgit exchange rate.

The FDA has reported US drug shortages, including ADHD medications, and has allowed imports of some chemotherapy drugs.

The Ministry of Health has proposed a strategy to address medication shortages.

The FDA tracks drug shortages and provides real-time information on their website.

Patients have the right to know about medication shortages and participate in their healthcare.

Adderall and liquid Amoxicillin are in short supply due to manufacturing issues and production delays, respectively.

The US prescription drug shortage list includes 250 medications, mostly generics that account for 90% of US prescriptions.

For patients with chronic pain, oral morphine is a slow-acting alternative to IV paracetamol.

Alternative medicines have the same effect as original medicines for patients with chronic conditions.

Cancer centers have reported shortages of key medications like carboplatin, cisplatin, and methotrexate, with 86% of centers experiencing anti-cancer drug shortages.

In Ireland, 216 medicines are unavailable, including most liquid antibiotics and dissolvable disprin.

Older drugs often face shortages after coming off patent due to reduced production.

A £5.3m support package is being finalized to help patients affected by shortages of osteoporosis and high blood pressure treatments.

Incident command centers and strategies like delaying elective exams can help hospitals respond to shortages.

Clinical pharmacists manage medication shortages by coordinating with medical teams and advising patients on safe and effective medicine use.

Taiwan's government has implemented a monitoring system to address medication shortages.

The University of Utah's Drug Information Service tracks drug shortages, providing valuable information for healthcare providers.

The FDA has set up a "Drug Supply Information Platform" to report and track medication shortages.

Patients with chronic diseases like motor neurone disease face challenges accessing medication due to stock shortages.

A shortage of essential drugs, including antibiotics and pediatric medications, is a growing concern, with eight out of 10 antibiotics unavailable in some regions.

In Egypt, the pharmaceutical market faces a severe shortage of various medications, including blood thinners, cancer treatments, and multiple sclerosis drugs.

Smart pill bottle technology and online portals monitor medication adherence and provide real-time patient data to pharmacies.

In Kenya, delays on the eCitizen portal have crippled health services and medication imports.

The FTC and US Health Department are investigating chemotherapy drug shortages reported by 93% of treatment centers.

The shortage of ADHD medications, including methylphenidate, has persisted for months, affecting patients of all ages.

The Tomny app provides real-time medication availability and allows user inquiries.

The CharmHealth platform offers real-time prescription benefits, electronic prescribing, and prescription price transparency.

The Samsung Health app offers a Medication Tracking feature with detailed medication information and interactions.

The Affordable Medicines program offers 486 free drugs and free medicine appointments with e-prescriptions from family doctors.

In Odessa, vital medicines, including insulin, are available in pharmacies.

A mobile app shows medication availability, alternatives, pharmacy locations, and contact information.

Patients can receive medications via electronic or paper prescription, and pharmacies can be filtered by medication availability.

In cases of medicine shortages, patients can call the Poison Control Helpline or consult their primary care physician or pharmacist for alternative solutions.

CareConnect and Gray's Compounding Pharmacy offer healthcare information and medication reviews with patient permission.

Patients are sometimes sent home with alternative medications, like paracetamol, due to drug shortages.

For patients with chronic life-threatening conditions, support systems can help with medication access.

The World Health Organization (WHO) supports healthcare and provides funding for life-saving treatments in countries like Syria.

A global medication shortage is affecting at least half a million patients, with 323 drugs in shortage in early 2024.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
An Unexpected Catastrophe in the World ’ s Largest Country: The Complete Story of U.S. Drug Shortages
The deficit is at a record level.
According to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service, organizations began tracking drug shortages for the first time in 2001. Steady since 2021 – now reaching a record high of 323 drugs in the first three months of 2024.
Paul Abramowitz, CEO of the American Society of Health System Pharmacists, wrote in a blog post on Thursday: “It ’ s been a long time to end drug shortages, ” and wrote:“ All drug classes are vulnerable to shortages, some of the most worrisome shortages include sterile injectable generic drugs, including cancer chemotherapy drugs and emergency drugs stored in hospital vans and procedural areas. It is dangerous for doctors and patients. ”
In addition to the 32 chemotherapy drugs that are deficient, the five categories of drugs with the greatest deficiency include central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids. [1] The Drug Deficiency Database maintained by the American Society of Health System Pharmacists and the University of Utah is based on voluntary reports from practitioners, patients, and others that have been confirmed by manufacturers. The U.S. drug is in short supply, because it captures broader effects on service providers and patients.
The crisis has lasted a year and a half.
More than half of the treatment shortages have lasted for more than two years, according to an analysis by health consultancy IQVIA, and the average shortage affects at least half a million patients, many of them elderly, according to the US Office of Health and Human Services under the Assistant Secretary for Planning and Evaluation, which shared its analysis with Congress in May.
Growing demand can play a role in drug shortages, as with the recent shortage of weight-loss drugs, but often manufacturing and quality problems, such as supply chain gaps and downtime, are the root cause. And varied.
But the American Society of Health System Pharmacists has “serious concerns ” about parts of this proposal, especially financial sanctions imposed on hospitals that lack the resources to comply with the recommendations, Abramowitz wrote:“ We all know that managing shortages is not enough and is not a sustainable solution to the worsening crisis, and there is still a lot of work to be done at the federal level to fix the root causes of drug shortages. ”
Why Shortage Occurs
Shortages can be caused by high demand, as with the recent shortage of weight-loss drugs, but this is not usually the main problem.
The FDA also blames manufacturing and quality problems, supply chain gaps, and downtime, and Dr. Emily Tucker, a drug shortage expert and an assistant professor of industrial engineering at Clemson University, says that when there is an indication of shortages, large health systems often also proactively place large orders, adding to the system ’ s stress.
“I don ’ t blame anyone.
“When I talk to all the stakeholders – whether it ’ s wholesalers, manufacturers, or the government – everyone wants this problem to end, ” she said.
Lack of transparency
Dr. Julie Grallo, chief medical officer and executive vice president of the American Society of Clinical Oncology, told the House Committee earlier that the shortage puts providers in a terrible position: “The drug shortage crisis is forcing providers to make impossible choices, and it is also hindering the development of new drugs. Health drugs are purchased only on a price basis, and manufacturers do not have to disclose the source of their acquisition of the ingredients.
The shortage of this generic chemical drug came due to the closure of one factory in India that manufactures the active ingredient after a surprise FDA inspection found “significant quality issues, ” says Jarallo:“ We didn ’ t know, and there was no transparency regarding the company ’ s supply of the majority of active pharmaceutical ingredients to all manufacturers across the board.
Knowing this in advance, we could have responded much faster, ” Dr. Steven Schundlemeyer, director of the PRIME Institute of the University of Minnesota School of Pharmacy, which focuses on economic and management issues, told the committee that as with defense contractors in the United States, New Zealand requires manufacturers to disclose their suppliers, and that information is required.
Easily accessible in the database.
Related Topics

The shortage affects various drug classes, including chemotherapy, stimulants, antimicrobials, hormones, and intravenous fluids.

Most drug shortages, which last over two years on average, are caused by manufacturing and quality problems.

Lack of transparency in the pharmaceutical industry hinders responses to drug shortages.

The US FDA tracks drug shortages and provides real-time information on their website.

Title:

Content: NORTHAMPTON, Mass. (WWLP) – While this shortage of chemotherapy drugs stretches across the country, 22News looks at how the limited amounts of potentially life-saving drugs are impacting cancer care in our area.

It’s a problem, so acute it was recognized by the Biden Administration just last month. The White House noted there’s a shortage of 15 cancer drugs due to manufacturing and supply chain issues.

22News asked Pharmacy Director Michelle Kososki at Mass General Brigham Cooley Dickinson Hospital, to rate the shortage experienced locally on a scale, 5 being a critical shortage and 1 being no shortage at all, “right now I would probably say it is a four. We only have a very small supply of one particular drug.”

Pharmacy Director Michelle Kososki said drug shortages are not uncommon in the healthcare industry however, when faced with potentially life-saving drugs it can get complicated, “Anytime there is a shortage, there’s a risk of not being able to treat patients. Obviously, that is something we want to avoid and we work to the best of our ability with creative solutions to make sure that doesn’t happen.”

Nurse Manager Lisa Martensson at Mass General Care Center at Cooley Dickinson Hospital told 22News, “There’s always the ethical issues of who gets the drug that’s available. It’s supply and demand as you said and looking at what folks had for their disease which ones needed to be treated faster than others based on the aggressiveness of their disease. Those things played in but it was a really difficult decision to sit down and try and decide who would get the drug. We were never in a position where we had to deny anybody.”

Cancer patient Norman Uzdavinis of Whately said he was very concerned when he first heard of the shortage, “I had wondered where in the chemotherapy I would be at, would it have to be delayed for months or years if possible.”

Uzdavinis has not had his medical care compromised but feels for those who have, “I feel for them. I know what I’m going through and that everything is here so it’s perfect for me, but there’s a lot out there that are not as fortunate. I know that.”

“Healthcare providers here were able to mitigate the shortage by using a couple of different tactics. For example, they could switch up a patient’s medication regimen,” Nurse Manager Lisa Martensson said.

“What we did do was use drugs that were in the same classification but not necessarily that specific drug. There are also drug regimens where we could switch around the order to which we gave the drugs so if there was a drug that wasn’t available we are able to do one of the drugs that was available first and do that second drug second. That was able to work out so people didn’t do without and they were able to get what they needed,” Martensson continued.

According to the FDA, the shortage started when one of the major manufacturers of the chemo drug, Accord Healthcare, a company based in India, had to shut down after problems complying with good manufacturing practices were found during an inspection. Now, there is an increased demand from other companies that make these kinds of drugs.

22News contacted some other of the manufacturers of these drugs. Pfizer said they are increasing production by about 40 percent to meet this increased demand.

Local News

Alanna Flood is a reporter who has been a part of the 22News team since 2022. Follow Alanna on X @alannafloodnews and view her bio to see more of her work.

Patients can consult pharmacists or healthcare professionals for information on medication shortages.

Title:

Content: Ireland has been suffering a paracetamol shortage as cases of Covid-19 and the winter flu in the country soared over the festive and new year period.

The revelation was made by Health Minister Stephen Donnelly after his department received notification of a supply issue from the Health Products Regulatory Authority.

It is understood the shortage impacted some prescription paracetamol products.

Read More:Irish people complain of ‘worst ever’ winter bug sweeping country that feels like Covid but isn’t

Two suppliers affected have stated that resupply will be sometime in January 2023.

However, there are other prescription paracetamol suppliers with some stock available on the shelves.

Paracetamol is one of the medicines used most often in Ireland and especially for the flu, aches and pain.

But Mr Donnelly pointed out that there are multiple forms of the drug with different strengths and brands available from various sources.

He said: "In the event that there are some supply issues for individual medicines, alternative options such as alternative strengths and brands, generic medicines will usually be available to ensure continuity of treatment.

"In some cases where the medicine initially prescribed for the patient is unavailable, patients may be switched to a suitable therapeutic alternative following appropriate consultation with a healthcare professional."

The Health Minister said medicine shortages have been increasingly prevalent worldwide over the past decade. The causes of such shortages are multifactorial including shortage of raw materials, manufacturing difficulties and industry consolidations.

He stated: "Medicine shortages can originate at any point in the supply chain. They can involve and impact many stakeholders in different ways as the supply models and clinical use of therapies can vary across national health systems.

"Management of medicines shortages necessitates a multi-faceted, multi stakeholder response to ensure patient safety , continuity of care and protection of public health.

"Patients or their carers who have any concerns in relation to temporary alternative products provided because of medical shortages are advised to speak with their pharmacist or other healthcare [professionals] involved in their care."

Mr Donnelly was responding to a number of written Dail questions on the shortage of medicines.

READ NEXT:

Get breaking news to your inbox by signing up to our newsletter

The Ministry of Health and Welfare has set up a drug supply notification center to provide real-time information on medication shortages.

Title:

Content: Policy and Inadequate Clinical Engagement Call on Government to Address Drug Deficiency and Enhance Patient Participation Rights
Health Care Network
The World Health Organization (WHO) has designated September 17 every year as World Patient Safety Day (referred to as Patient Safety Day), but patient participation in China is still insufficient from policy to clinical.
The Taiwan Alliance of Patients and Friends (TAPO) today (13th) invited patient groups and medical organizations to celebrate World Patient Safety Day, calling on the government to actively address the crisis of drug shortage and implement three important rights of patients in the medical and health care system: the right to know, the right to choose and the right to participate.
This is an advertisement, please continue reading.
The Taiwan Alliance of Patients and Friends (TAPO) held a press conference on World Patient Safety Day 2023 on the 13th, inviting the two major competent authorities of the Ministry of Health and Welfare, the Ministry of Health and Welfare, the Ministry of Health and Welfare, the Department of Health, the Association of Pharmacists, the Association of Nurses, the Medical Reform Foundation, and the Pharmaceutical Relief Foundation to jointly advocate for patient safety.
Call on the Ministry of Health and Welfare to actively respond to the drug shortage crisis
Wu Honglai, president of TAPO, pointed out that a stable supply of drugs is the basis of drug safety. At the beginning of this year, the shortage of drugs in China worsened, and the public may not be able to obtain the required drugs in community pharmacies.
The Ministry of Health and Welfare subsequently set up a drug supply notification processing center, but the problem of drug shortage at the grassroots level is still reported.
Now the global shortage of drugs continues to fever, the United States official also confirmed that the lack of drugs for several months, in addition to pain medication, even cancer drugs, antibiotics are in crisis.
Faced with such a challenge, Taiwan is also a small market, low health insurance cost of the country, I am afraid that it will be no small impact, imploring the Ministry of Health and Welfare to put forward a more positive response to the shortage of drugs, so that patients will not suffer from the interruption of treatment.
Chen Wen-wen, CEO of the Drug Harm Relief Foundation, believes that "drug safety" is an important part of maintaining patient safety. From years of experience and research, many serious drug hazards can be prevented beforehand. In all stages of treatment, such as receiving prescriptions, taking drugs, and tracking the effectiveness of treatment, you must have a deep understanding of the relevant information in order to escape the passive acceptance of instructions and actively restore health.
Enhance patient participation and influence
Yan Biwen, deputy executive director of the Cancer Hope Foundation, suggested that the current time point for patients to express their views is worth discussing again, and the expert meeting has completed the drug payment proposal before the expression, for discussion by the Joint Committee, and the views of patients are difficult to exert practical impact.
The government should refer to the practices of leading countries such as the United Kingdom, Australia and Canada to include the views of patients in the medical technology assessment, including subsequent expert meetings and meetings to decide on payment, and have formal representatives of patients to participate in the discussion and resolution.
This year, the Health Insurance Department visited the Cancer New Drug Fund of the United Kingdom and cooperated with NICE in the United Kingdom. It should also follow its patient-centered spirit, enhance the participation of patients and expand the scope and influence of collecting opinions.
“Healthcare is not just about treating diseases, it ’ s about caring for and protecting lives, ” said Su Yuyi, deputy general secretary of the All Union of Physicians. Since 105, doctors have been promoting shared decision-making. Instead, they discuss treatment options, risks and benefits with patients to help them make decisions that meet their values, preferences and goals.
Cai Li-chuan, deputy executive director of the Taiwan Cancer Fund, believes that at present, the participation of patients' representatives in the important decision-making meeting of health insurance is still insufficient. In the "joint drafting" meeting to decide whether drugs should be included in the health insurance payment, there are only two patients present, and informal representatives, there is still a gap in the exercise of the rights of the meeting. Members who have obtained seats by drawing lots, so that the voices of patients are easily ignored.
Competent authorities should plan a more stable and sound system for patient participation, and pay attention to the voice of patients.
Patient safety should be ensured by maintaining a stable ratio of care
According to a study by Linda Aiken, a professor at the School of Nursing at the University of Pennsylvania, the probability of death of surgical patients within 30 days of admission increases by 7%.
Source: Healthnews.com https: / / www.healthnews.com.tw / readnews.php? id = 59248
Please like this article and share it with your friends! More health information: https: / / www.healthnews.com.tw
This is an advertisement, please continue reading.

The Drug Deficiency Database tracks drug shortages, informing patients and caregivers about medication shortages.

Healthcare systems and pharmacists can manage medication shortages by prioritizing treatment and offering alternative therapies.

Title:

Content: As drug shortage list grows, many hospitals face tough decisions on rationing care

More than half of hospital pharmacists are reporting a critical shortage of chemotherapy drugs and nearly all are reporting overall medicine supply gaps as prescription drug shortages near an all time high, according to a new survey.

Hospital pharmacists said drug shortages have forced 1 in 3 health systems to delay, cancel or ration care or switch to alternate drugs to continue to treat patients. And 99% are reporting some drug supply shortages, an American Society of Health-System Pharmacists survey of more than 1,000 pharmacists released Thursday found.

The organization reported shortages of 309 drugs, near the all-time high of 320 shortages in 2014. The scarcity of key drugs is prompting hospitals to find or substitute drugs and change treatment plans as needed.

“In some cases, there are no alternatives to the affected drugs, which puts patients at risk," ASHP Chief Executive Officer Paul W. Abramowitz said in a statement. "This issue requires quick action from Congress to address the underlying causes of shortages and ensure patients have the medications they need.”

Cancer drug shortages

In June, the Food and Drug Administration said it will temporarily allow overseas drug manufacturers to import some chemotherapy drugs.

The FDA allowed Qilu Pharmaceutical, a drug manufacturer in China, to import the injectable chemotherapy drug cisplatin in 50-milligram vials. Toronto pharmaceutical company Apotex Corp. will distribute the medication in the United States.

More than a dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin, used to treat lung, breast, prostate and gynecologic cancers. The National Cancer Institute said cisplatin and similar drugs are prescribed for 10% to 20% of all cancer patients.

In June, the National Comprehensive Cancer Network released a survey of 27 academic cancer centers that found 93% reported shortages of carboplatin and 70% faced shortages of cisplatin.

When cancer hospitals face such shortages, they attempt to make sure there's enough medication for patients to finish the course of treatment, said Mike Ganio, ASHP's senior director of pharmacy practice and quality.

Cancer hospitals facing such shortages might change medications for new patients starting on chemotherapy, said Ganio, a former pharmacy manager at an academic cancer center.

"You try to keep that patient on the same regimen as much as you can, unless they're failing it for some reason, and then you would switch," Ganio said.

Steroids, hormonal drugs also in short supply

More than 1 in 5 hospital pharmacists also reported shortages for steroids, hormonal drugs and oral liquids such as lidocaine, ibuprofen and amoxicillin.

A smaller number of pharmacists said heart medications, emergency prefilled syringes and drugs used for intensive care unit patients were in short supply. Others reported shortages of attention deficit hyperactivity disorder medicines, antimicrobial drugs and injectable opioids.

In all, about two-thirds of pharmacists said the shortages were "moderately impactful," which means they are managing shortages but patients are affected.

Pharmacists are managing the shortages by offering therapeutic alternatives, buying different vial sizes or concentrations and rationing medicines.

This article originally appeared on USA TODAY: Survey: Drug shortages are widespread, hospitals ration care

Healthcare providers and pharmacists must work together to minimize drug interactions and ensure safe medicine use.

Title:

Content: Our doctor.
More specialization, precision and care
Prepared by: Pascal Mouawad Boumaron
Success, progress and excellence are the hallmarks of our military medical pioneer in the field of health care as certified by all.
Today, it is adding to its advanced service record the creation of a clinical pharmacist position in the medical staff of the Central Military Hospital.
The long-term vision of military medicine is to shift to more specialization within all its departments, targeting precision in treatment plans and better patient care and safety outcomes, thereby promoting quality-based medicine.
Who is the Clinical Pharmacist?
What is the added value of being in the hospital?
And how does it work with the rest of the medical staff?
Dr. Rasha Al-Haj Shehadeh, a clinical pharmacist at the Central Military Hospital, answers these and other questions and explains the importance of the role of the clinical pharmacist in providing high quality health care services and in ensuring the safe and effective use of medicines for patients, including the use of appropriate alternatives when the essential medicine is not available.
Management of Pharmacotherapy
A clinical pharmacist is a pharmacist who holds a master ’ s degree in clinical pharmacy or a doctorate in pharmacy (pharm D) and undergoes additional specialized training in hospitals, clinics and healthcare facilities to ensure that a patient-focused pharmacotherapy is managed in collaboration with healthcare providers.
His work focuses on two areas: on the one hand, he coordinates with the medical team of doctors, nurses, nutritionists and physiotherapists in order to adopt the best treatment, and on the other hand, he follows up with patients on the development of their medical condition and how they interact with prescribed medications.
The role of clinical pharmacists within the hospital is integrated with the roles of the rest of the medical staff. One of the results is to reduce the cost of drug treatment during the patient ’ s stay in the hospital, choose the optimal treatment at the most appropriate time, and participate in quality improvement plans to ensure safe and effective drug treatment.
In addition to the above, it helps coordinate clinical research and case reports and is a source of information on drugs and trials as well, leading to improved and improved health care.
This is how we work together
The clinical pharmacist is the link between healthcare professionals and is keen to deal with patients from multiple backgrounds to provide a positive environment and achieve the best results.
Dr. Alhaj Shehadeh stresses the importance of coordination between the doctor and the clinical pharmacist in terms of enhancing the confidence of patients and their sense of security about the medical services they receive.
She explains that while the doctor develops a treatment plan, the clinical pharmacist elaborates it and ensures the safety of its application.
They coordinate by assessing and determining the patient ’ s state of health, consulting to find the most appropriate medication in accordance with the treatment plan, and monitoring the patient ’ s response.
This complementary relationship enhances patient care and quality assurance.
Collaboration with the nurse in charge is the development of policies and procedures to ensure that the quality and effectiveness of drug treatment is improved, while minimizing the side effects of mismanagement or drug interactions in general.
In this context, care is taken to examine the appropriate dosage and composition of the prescribed drugs, by calculating, measuring and mixing the quantities of drugs and other components required.
As for cooperation with the hospital pharmacist, Dr. Al-Haj Shehadeh explained that this cooperation includes ensuring that all precautionary medicines are properly stored in all hospital units, rationalizing their dispensing and management in accordance with international standards, and helping to monitor and check them periodically, especially those under control, such as tranquilizers, drugs and some antibiotics.
In addition, the clinical pharmacist advises patients on their medical condition, discusses their medications and their side effects, establishing a relationship of trust through continuity of care, ensuring confidentiality and privacy, and guiding them to comply with treatment after discharge, whether in terms of medication list and schedule, or the lifestyle best suited to their recovery or living with their condition.
SKILLS
The clinical pharmacist is interested in many basic tasks at once, says Dr. Alhaj Shehadeh, the most important of which is organization and scheduling, and his analytical skills are the basis for developing a treatment plan, after linking all the information from the patient ’ s history and current medical condition and analyzing it, to consider alternatives, especially since the medical situation in Lebanon is difficult.
Therefore, the clinical pharmacist should also be meticulous and attentive to every detail, whether in the patient ’ s laboratory results or in his / her medications, their quantity, and ensure that they are described in an optimal manner.
On a personal level, he must be courteous, courteous and courteous with the medical team and patients to strengthen his previously mentioned effective role and win the trust of all.
The integration of the clinical pharmacist within the military hospital is an important step towards improving the well-being of patients in the hospital, as well as towards reducing the risks related to drug errors.
This is compelling evidence of the commendable work of the military leadership to respond to and apply international standards even in the most difficult situations and circumstances.
Clinical Pharmacy and Lebanese Legislation
The Syndicate of Pharmacists in Lebanon has proposed a law on clinical pharmacy that stipulates that it is mandatory to adopt it in all Lebanese hospitals and that the number of clinical pharmacists in the hospital should be according to the number of beds in it, and the law is currently under discussion in parliamentary committees.

Check the current shortage status of your parent's medications to see if they're affected by global shortages.

Title:

Content: US supply chain crisis continues, FDA points to 111 drug shortages
Global Social Hotspot 16: 35 2021 / 12 / 05
Share:
The supply chain crisis in the United States continues, and many goods are facing shortages.
The US media said that the US pharmacies have a number of critical prescription drugs in stock. The US Food and Drug Administration (FDA) pointed out that about 111 drugs are out of stock in the United States. The FDA stressed that it will continue to take measures to monitor the supply chain.
【 Omicron variant 】 Travellers must have a negative test within 48 hours for entering the United Kingdom 【 Next 】
The Federal Reserve warned on Wednesday that large parts of the United States had begun to be affected by supply chain disruptions and labor shortages last month.
According to the FDA website, 111 drugs are out of stock in the United States, including the heart disease drug digoxin injection, the chemical drug Dacarbazine and some antibiotics.
The authorities say there are many reasons for the shortage, including production problems, quality problems, drugs and even the suspension of production.
According to the FDA, about 80% of the manufacturers of active pharmaceutical ingredients are located overseas, and the manufacturers have provided the FDA with most of the drug shortage information.
The Administration will also work closely with these manufacturers to address the drug shortage.
【 Omicron variant 】 Study: Omicron carries a cold virus gene or helps avoid the immune system 【 Next 】
Long Island Newspaper Newsday quoted Tom D'Angelo, president of the New York State Association of Pharmacists, as saying the shipping of a large number of medicines, including those for common blood pressure and for the treatment of colds and flu, was blocked.
Because of supply chain problems, the owner of a New York drugstore said there were fewer brands for some drugs, including Ibuprofen.
The National Association of Community Pharmacists (NCPA) released a survey last month that found that most non-chain pharmacies are struggling to fill employee vacancies and cope with supply chain disruptions.
Sixty percent of pharmacies surveyed said they were dealing with supply chain disruptions, and nearly 70 percent said it was difficult to fill staff vacancies.
Stay abreast of the latest development of mutant virus and epidemic vaccine, download the Hong Kong Economic Times App for free now 【 Click here
Editor-in-Chief: Cheng Kam-ling
Follow the latest financial news analysis, like hket Facebook
Subscribe to the Hong Kong Economic Times email newsletter
Receive first-hand financial news Learn more about investment and financial knowledge Submit my consent to receive promotional messages from Hong Kong Economic Times Group. You may also check the privacy policy of this website Terms of Use

Title:

Content: Meitu
The first quarter of the United States serious drug shortage 323 drugs urgent cancer patients also have to be diverted and rationed!
CHU HENG NETWORK NEWS CENTER 2024-04-16 10: 42
According to the latest data from the American Society of Health System Pharmacists (ASHP) and the Utah Center for Drug Information Services, a total of 323 drugs in the United States were in severe shortages in the first quarter of this year, surpassing the record of 320 in 2014.
Among the drugs affected are the widely used diabetes drugs Ozempic and Mounjaro, the allergy treatment drug adrenaline, the common antibiotic amoxicillin for children, chemotherapy drugs and injections commonly used in hospitals in intensive care.
ASHP CEO Paul Abramowitz said in a statement that almost all categories of drugs are facing shortages, with non-patented sterile injectable drugs, including cancer chemotherapy drugs, and emergency drugs stored in hospital emergency vans and operating areas, the shortage of such drugs is the most worrying.
According to the American Cancer Society, chemotherapy is one of the top five drugs most affected by the shortage, which threatens to have a devastating impact on patients, and some hospitals and clinics say doctors have had to divert patients to ration their medications because of a shortage of some chemotherapy drugs.
In addition, ASHP noted that the continued nationwide shortage of ADHD drugs is “a problem for clinicians and patients. ”
The shortage of popular drugs is even more acute, with Mounjaro, the diabetes drug known as the “slimming pill ”, already in dire straits.
In response, Lilly said that the “unprecedented surge in demand ” for Mounjaro and its similar drug Zepbound has led to a shortage in the market, which the company is struggling to cope with.
Lilly is ramping up investments to boost production at Mounjaro and Zepbound in the second half of 2024.
The company said it expects intermittent supply disruptions in the near term due to unprecedented demand.
How to cure the drug shortage
The last major “drug shortage ” in U.S. history occurred in 2014, and it has only been alleviated in the years since.
Since 2021, the drug shortage situation seems to be increasing, and scholars in the field of medical health and economics in the United States believe that the reason for most drug shortages in the United States is the fragmentation of the drug supply chain.
The White House this month proposed spending between $3.26 billion and $5.11 billion over the next decade to help address the nation ’ s drug shortage.
The bill requires approval and funding from the U.S. Congress.
U.S. researchers and policymakers believe that a complete solution to the “drug shortage ” may require changes to the business model of the U.S. pharmaceutical industry, including measures to increase the price of generic drugs to attract more drug manufacturers.
Policymakers recommend giving the FDA more power to access more information about drug shortages and impending shortages.
Currently, the FDA relies primarily on phone calls to manufacturers asking if they can increase their supply to understand the situation.
The American Society of Health System Pharmacists said it is working with the federal government to advise the government on measures to address the drug shortage, including that Congress should require manufacturers to be more transparent on any supply chain issues and encourage more diversity in supply chains.
According to Abramowitz, “The federal government still has a lot of work to do to fundamentally address drug shortages, and the American Society of Health System Pharmacists will continue to engage regularly with policymakers to guide them in drafting and passing new legislation to address drug shortages and continue to advocate vigorously for proven solutions on behalf of our members. ”

Title:

Content: 2 major drugs are in short supply, FDA says. Both are widely prescribed to children.

NEW!

Drug shortages continue in the U.S., even as the COVID-19 pandemic nears the end of its third year.

Two drugs commonly prescribed to children — Adderall and liquid amoxicillin — recently joined the list, the Food and Drug Administration says.

The FDA announced last month that it was talking to manufacturers about a shortage of Adderall, the combination drug of amphetamine mixed salts used to treat attention deficit hyperactivity disorder.

Parents are also discovering liquid amoxicillin — an important antibiotic used to treat bacterial infections — is in short supply, according to the FDA. It added the oral solution of the antibiotic to its list of drug shortages on Oct. 28.

Both drugs are widely used by children as well as adults. The amoxicillin shortage comes at a vulnerable time, as we enter cold and flu season and U.S. hospitals continue to fill with respiratory infections. Amoxicillin is often used to treat ear infections and bronchitis.

The reason for the shortages? The FDA didn’t immediately respond to a request for comment Thursday. However, the agency cited a few factors on its website, including quality and manufacturing issues.

“There have been other reasons such as production delays at the manufacturer and delays companies have experienced receiving raw materials and components from suppliers,” the agency says. “Discontinuations are another factor contributing to shortages.

“FDA can’t require a firm to keep making a drug it wants to discontinue. Sometimes these older drugs are discontinued by companies in favor of newer, more profitable drugs.”

For a list of all drugs currently in short supply, visit FDA.gov.

Our journalism needs your support. Please subscribe today to NJ.com.

Spencer Kent may be reached at skent@njadvancemedia.com.

If you purchase a product or register for an account through one of the links on our site, we may receive compensation.

You can use online resources like the FDA website to stay informed about medication shortages and find alternatives.

You can consult with your parent's healthcare provider or pharmacist to discuss alternatives and manage their medication regimen during a shortage.

Drug shortages are mainly caused by manufacturing and quality issues, high demand, and currently affect 32 chemotherapy drugs.

Lack of transparency in the pharmaceutical supply chain hinders addressing drug shortages and patient access to needed medications.

The US government has proposed $3.26-5.11 billion to address shortages, and the FDA seeks more power.

A generic drug price increase may alleviate shortages by attracting more manufacturers.

Most treatment shortages last over two years, affecting at least half a million patients.

If your parent takes Amoxicillin, Adderall, or Methylphenidate, they may be affected by the global medication shortages.

Title:

Content: Patients with Attention Deficit Hyperactivity Disorder (ADHD) are being forced to pay hundreds of euros for medication that is usually supplied free of charge by the government.

A shortage of various dosages of Methylphenidate is affecting patients of all ages, including young children who rely on the medication to maintain their day-to-day routine which includes going to school.

If they do not take their medication, I will have no option but to take them out of school- Parent David Brooks

David Brooks, the father of two boys aged six and nine with ADHD, said he was recently informed that the medication was unavailable.

This was a repeat of what had happened in March, he noted.

Brooks said he had not been given any explanation by the pharmacy and was simply told there were issues at the government’s Central Procurement and Supplies Unit.

The government replied to questions on the issue on Wednesday evening, saying it was expecting the medication to arrive in the coming days.

Procurement from UK takes longer due to Brexit

“Since these products are being imported from the UK, a different registration process must be triggered due to Brexit, which unfortunately lengthens the procurement process,” a spokesperson said.

But for now, Brooks has no option but to purchase the medication at a cost of more than €250 every month.

He is afraid that, if the shortage persists, he may not be able to cover the expenses each and every month.

“I can get the money for the next month or two but longer will be a problem. If they do not take their medication, I will have no option but to take them out of school,” Brooks said.

He also called on the authorities to, at least, provide information to families who have been impacted.

A spokesperson for the NGO ADHD Malta said the issue has persisted for months. The medication is “very expensive” and those with ADHD do not benefit from any kind of allowance.

The spokesperson added that relying on agents who supply the drugs privately may not be a long-term solution since they also have limited stock.

These agents, she said, would need to plan ahead.

This is not the first time that issues with ADHD medications have made headlines.

In 2021, there were calls on the government to revert to branded medication as the treatment offered for free was having a detrimental effect on some of the children and adults.

This issue is still unresolved, the NGO says.

Independent journalism costs money. Support Times of Malta for the price of a coffee.

Support Us

You can use online resources like the Tomny app or CharmHealth platform for real-time medication availability and alternative treatments.

Title:

Content: Saudi News
“Know Your Choices ” Campaign Reveals Drug Alternatives and Prices
Thank you for reading the news « Know Your Choices » campaign reveals the alternatives of medicines and their prices and we assure you that we always seek to satisfy you and now with the details
- By Ayman Al-Weshwash - To raise consumer awareness of the service of knowing the prices of medicines and their alternatives through the application « Tomny », the Saudi Food and Drug Authority implemented an awareness campaign entitled « Know your options » in the areas of Riyadh and Sharqiyah.
The campaign focuses on identifying the correct way to read the data on the medicine package, how to identify the price of the medicine, and the options and alternatives available by reading the barcode printed on the package.
The campaign includes an awareness stand where samples of different medicines are available, in order to explain the alternatives of medicines, and ways to identify their prices and differences between them, with the presence of specialized pharmacists to answer the inquiries of visitors.
The campaign coincides with the presence of printed and electronic awareness materials in some private pharmacies to raise awareness of the ways of knowing the prices and alternatives available for medicines. Beneficiaries can download the application « Tomny » available in Arabic and English on the operating systems « IOS » and » Android » through the link (https: / / tameni.sfda.gov.sa).
The "Tomny" application of the "Authority" provides information about the alternatives of approved medicines, which makes the consumer aware and aware of the prices of medicines and their alternatives before buying, by reading the "barcode" printed on the package, through the application.
Tamny allows sending inquiries, complaints or reports about the unavailability of medicines, and facilitates the application of searching for pharmaceutical and food products and medical devices by name or barcode, and provides accurate and important tips and information about those products.
In order to ensure the availability of the drug at the points of sale, and not to withdraw it to modify the printed price, and to ensure the immediate adjustment of the prices of drugs electronically when updated by the Authority, and to allow the competition between companies to sell less than the price set by the Authority without allowing them to increase it. The highest price.
The Food and Drug Administration (FDAA) will continue its awareness campaign through the establishment of pavilions in Makkah, Jazan and Tabuk in the coming days.
The application of clay provides:
Information about approved drug alternatives
• Knowledge of the scientific and commercial name of the product
• Method and reasons of use
• Pharmaceutical form
• Shelf life
• Proper storage conditions for the product
• Type and size of packaging
Does the product need a prescription or not?
• Tamny allows sending inquiries or complaints
• Facilitates the search for pharmaceutical and food products and medical devices
• Provides accurate and important advice and information about these products
This was the details of the news « Know Your Choices » campaign reveals the alternatives of medicines and prices for today, we hope that we have succeeded by giving you the details and full information and to follow all our news you can subscribe to the alerts system or in one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available on Mecca has been confirmed by the editorial team in Gulf 365 and may have been modified and may have been transferred in full or quoted from it and you can read and follow up on the news from its main source.
You may also read.

Title:

Content: CharmHealth, MedicalMine's Cloud-Based Health-Tech Platform, Launches Integrated Real Time Prescription Benefits With Electronic-Prescribing for Controlled Substances

CharmHealth's integrated Real Time Prescription Benefits with Electronic-Prescribing for Controlled Substances (EPCS) adds another layer of efficiency to medical practices, while improving patient satisfaction.

Pleasanton, UNITED STATES

PLEASANTON, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- MedicalMine Inc.'s CharmHealth suite of products is a leading comprehensive solution including Electronic Health Records (EHR), Practice Management (PM) and Revenue Cycle Management (RCM) for independent medical practices.

Independent Clinics all over the country use CharmHealth to prescribe controlled substances to their patients, in compliance with regulations. CharmHealth has now rolled out the much sought-after Surescripts Real-Time Prescription Benefits (RTPB) solution, integrated within the eRx (Electronic-Prescription) module at the point of care. This delivers prescription price transparency and therapeutic alternatives that benefit patients and clinicians bringing greater efficiency, reduced costs, and increased patient satisfaction.

The Real-Time Prescription Benefits solution will enable friction-less doctor-patient interaction by enabling meaningful conversation at the point of care, enabling patients to save money, improving medication adherence, and reducing pharmacy callbacks or alternatives considered by patients without consulting with the physician.

CharmHealth's Real-Time Prescription Benefit enables clinicians to rapidly determine if a prior authorization is required, and view therapeutic alternatives including those that may not require prior authorization, all within their EHR workflow. "Accurate and effective prescription medications are the cornerstones of any medical provider's tool-chest. As a result, CharmHealth EHR strives to provide real-time solutions that aid that workflow, saving time and bringing economical alternatives to the patient. CharmHealth's RTPB used together with Electronic Prior Authorization and E-Prescribing, creates the ideal prescribing scenario and simplifies every prescription decision," says Pramila Srinivasan, CEO, MedicalMine Inc.

"A prescriber and patient conversation about prescription pricing in the moment of care can lead to better adherence," said Andrew Mellin, MD, VP, Chief Medical Information Officer at Surescripts. "Surescripts Real-Time Prescription Benefit arms MedicalMine prescribers with accurate information on prescription pricing and prior authorization requirements so that prescribers can make the best medication decisions with their patients."

CharmHealth is created by a California-based company, MedicalMine Inc., a leading cloud-based health IT platform for independent practices. CharmHealth's mission is to empower independent medical groups with clinical and financial technology tools that improve provider experience and patient outcomes.

CharmHealth's integrated cloud-based product suite is built to provide superior patient care, reduce delivery costs, and provide exceptional access to patients' medical data. CharmHealth includes Electronic Health Records, Practice Management, Patient Portal for Patient Engagement, Revenue Cycle Management, TeleHealth solutions, and an Instant Messaging solution for Providers, CharmConnect, all with complementary mobile solutions.

For more information on CharmHealth, visit https://www.charmhealth.com. To get breaking news on CharmHealth, follow the company on Twitter at https://www.twitter.com/charmhealth and Facebook at https://www.facebook.com/charmhealth.

Related Images

Image 1: RTPB

Real Time Prescription Benefit

This content was issued through the press release distribution service at Newswire.com.

Attachment

Contact Data

These resources provide information on approved drug alternatives and accept inquiries and complaints.

Consult with your parent's healthcare provider or pharmacist to discuss alternatives and manage their medication regimen during a shortage.

Patients may need to renew their residency or explore alternative options to access necessary medications.

Title:

Content: Sunday, 17 March 2024 10: 18 GMT
Medicines for the elderly and the disabled
(MENAFN- Al-Anbaa)
Many elderly people and people with disabilities with special needs suffer from some of the problems they face in many aspects of daily life, including the lack of availability or access to appropriate treatment prescribed for them in some medical centers and hospitals, especially those with severe diseases such as diabetes, heart, kidneys, eyes, etc., because they are not available in the mentioned pharmacies, and their prices are high. Civil society mechanisms and private hospitals, which cause them to multiply their pain and poor conditions and expose them to dangers resulting from that delay, and such “should not happen in the prosperous state of our beloved Kuwait. ”
It is necessary to have a system to deliver them through modern means, as was the case during the Corona disaster, and to have a system to deliver them according to the title and accurately work through the contributions of our cooperative societies, and to prevent the manipulation of some of this important medical issue and the health of the declining bodies to search for the source of medicine suitable for each performance, especially for the elderly and cases of disability....
From a humanitarian point of view, expatriates must be included in general according to a specific mechanism and based on the health insurance they pay when renewing their residency.
Our wishes for safety for all on the land of safety and giving, Kuwait Humanity.
MENAFN17032024000130011022ID1107987532
Legal Disclaimer:
MENA Financial Services Network provides information "as is" without any representations or warranties...
This disclaims our responsibility for the privacy practices or content of the sites included in our network, including images and videos.
For any queries regarding the use and reuse of this source of information, please contact the provider of the above article.

The World Health Organization (WHO) supports healthcare and provides funding for life-saving treatments in countries like Syria.

Title:

Content:
Syria + 1 more

Kuwait supports essential health system availability in Syria with additional USD 3 million

Format
News and Press Release
Source
Posted
Originally published

12 August 2021, Damascus, Syria – WHO welcomes a new donation from the Kuwait Fund For Arab Economic Development to support health care for all people-in-need in Syria. This new contribution of US$ 3 million comes at a critical time as the health system faces shortages in resources due to sanctions and is overwhelmed by the ongoing COVID-19 pandemic.

“Kuwait has been a long-standing partner to WHO in our work to save the lives of the Syrian people. We are grateful for this generous contribution which has come as a major step towards reviving the availability of health care services to all people-in-need, and supports WHO’s commitment to alleviate the immense suffering of the Syrian people,” said Dr Akjemal Magtymova, WHO Representative and Head of Mission in Syria.

Gaps in local production of medicines within Syria have left significant shortages in much-needed essential medicines, especially for patients with chronic conditions. Noncommunicable diseases are now the highest cause of morbidity in Syria, accounting for 45% of all deaths in the country. This new funding will enable WHO to increase access of vulnerable people to life-saving treatment for noncommunicable diseases, including asthma and chronic pulmonary conditions, cancer, cardiovascular disease, diabetes and kidney failure.

With this generous support, WHO will also continue strengthening the COVID-19 response, as well as support the national immunization programme in the implementation of COVID-19 vaccination campaigns targeting high-risk groups, including internally displaced people and host communities.

Part of the funds will also be used to purchase five fully equipped ambulances that will boost national efforts to strengthen the management of trauma cases, increase access to health care services, and facilitate transportation and referral of emergency cases among internally displaced people and host communities to the nearest health facility. As the crisis enters its eleventh year, 6.1 million people remain internally displaced and are at increased risk of infectious diseases due to limited access to safe water and sanitation, overcrowding and other risk factors. In Syria today, there are cases of epidemic-prone diseases like acute diarrhoea, leishmaniasis, and suspected hepatitis.

As of June 2021, only 47% of public hospitals are fully functioning, resulting in access to health services to millions being crippled. Shortages of trained health workers are very visible on the ground, as a result of more than a decade of war, and a declining economic situation.

“Syria is experiencing a protracted political and socio-economic crisis that has resulted in a severe deterioration of living conditions. The scale, severity and complexity of humanitarian needs remain extensive. The health system has taken a devastating blow as a direct result of the crisis and aggravated by the sanctions coupled with the ongoing COVID-19 pandemic. Long-standing partners to WHO, such as the Government of Kuwait, help WHO ensure that health care services to all vulnerable Syrians continue uninterrupted, and helping us fulfil our common vision of Universal Health Coverage and health care for all by all,” added Dr Magtymova.

Medication shortages require a multifaceted approach, including support for patients with chronic life-threatening conditions.

To prepare for future shortages, stay informed, consult with your parent's healthcare provider or pharmacist, and explore online resources.

Consider reaching out to patient support groups or advocacy organizations for guidance.

You can encourage your parent's healthcare provider to report medication shortages to the FDA.

Title:

Content: The lack of medicine continues to burn!
The Ministry of Health and Welfare has proposed a short, medium and long-term strategy to deal with the current 5 coping mechanisms.
Journalist Yen Zhenzhen / Taipei Report
According to the Ministry of Health and Welfare, the shortage of drugs is not a single factor, but includes supply problems, manufacturing problems, clinical demand factors, uneven distribution of drugs, drug use habits and drug prices. In addition to dealing with the relatively high clinical demand items, it is properly allocated to all levels of medical institutions and pharmacies to fully meet the needs of clinical end-use drugs.
This is an advertisement, please continue reading.
In the face of the shortage of drugs, Wang said, the existing health insurance uses five major coping mechanisms, including 1, a single processing window, a dedicated person to help deal with the problem of drug purchase, and contact the Food and Drug Administration to put relevant information on the website of the NHI. (4) Drug price adjustment mechanism that does not meet the cost can be re-checked according to the way of raising the price of special drugs; (5) Alternative drugs can still declare the cost, if they are not irreplaceable, they can be replaced at the same price or lower than the original prescription drug price.
In addition, Wang pointed out that in the face of the international epidemic, the Russian-Ukrainian war, and labor shortage, drug shortage is a problem facing all countries. In order to strengthen the stable supply mechanism of drugs in China, the Ministry of Health and Welfare continues to actively respond to the short-term strategy to solve the problem of drug shortage. The Food and Drug Administration (FDA) and the pharmaceutical industry have made every effort to actively arrange production lines, strive for early import, increase production / import quantity, and properly distribute to all levels of medical institutions and pharmacies to fully meet the demand for clinical end use drugs.
In addition, to properly handle the issue of drug price adjustment, the Central Health Insurance Administration of the Ministry of Health and Welfare intends to implement the "Universal Health Insurance Cost Distribution Target System (DET)" in April this year, which will adjust the number of drug prices and adjust the quota in a suitable manner, taking into account factors such as the epidemic, the Russian-Ukrainian war and inflation.
In terms of medium-term strategy, Wang said that he will establish a permanent drug shortage treatment center and optimize drug supply information transmission.
In order to speed up the handling of drug shortage incidents, we will adopt dedicated personnel and cross-departmental cooperation to develop drug shortage prevention policies to prevent drug shortage in advance, strengthen cross-departmental data integration and proactive monitoring to detect drug shortage incidents at an early stage, and intervene early through cross-departmental cooperation to stabilize drug supply.
At the same time, the Food and Drug Administration (FDA) continues to disseminate drug supply and alternative drug information through various channels. In addition to posting on the “Drug Supply Information Platform ”, the FDA will notify medical institutions and pharmacies through VPN, and weekly letters to relevant medical associations and public associations to inform members. Management system.
In the long-term strategy section, it includes reviewing the current health insurance drug pricing policy and encouraging the production of domestically manufactured generic drugs.
Wang Bi-sheng pointed out that in the review of the current health insurance drug price policy, including the development of the price protection of indicative drugs, drug price review for the lack of drugs; start the review of drug expenditure target (DET), plan the establishment of a risk control mechanism, plan the national unified procurement trial plan; comprehensively review the health insurance drug price policy, give an appropriate price protection mechanism for necessary drugs, and also target the patent period. To encourage the production of domestic manufacturers to ensure that when there is a shortage of original pharmaceutical products, there are domestic famous drugs to respond.
Wang also stressed that the Food and Drug Administration has set up a "Drug Supply Information Platform" (https: / / dsms.fda.gov.tw /), reporting hotline (02) 27878249. If medical institutions and pharmacies have any shortage of drugs, they can go to the platform for enquiry or notification, and the department will deal with it immediately.
This is an advertisement, please continue reading.

By working with healthcare providers and support groups, you can help your parent receive necessary care during a medication shortage.

References:

References:

The US had a record 323 drug shortages by 2024.

The US had a record 323 drug shortages by 2024.

The US had a record 323 drug shortages by 2024.

France reported 4,925 drug shortages in 2023, affecting 44% of the population by 2024.

France reported 4,925 drug shortages in 2023, affecting 44% of the population by 2024.

France reported 4,925 drug shortages in 2023, affecting 44% of the population by 2024.

The European Union announced pharmaceutical industry reform measures.

The European Union announced pharmaceutical industry reform measures.

The European Union announced pharmaceutical industry reform measures.

In the US, 111 drugs were out of stock in 2021, with the FDA monitoring the supply chain for shortages.

In the US, 111 drugs were out of stock in 2021, with the FDA monitoring the supply chain for shortages.

In the US, 111 drugs were out of stock in 2021, with the FDA monitoring the supply chain for shortages.

A global shortage of antibiotics has occurred, with 28 of 35 countries lacking penicillin-type drugs.

A global shortage of antibiotics has occurred, with 28 of 35 countries lacking penicillin-type drugs.

A global shortage of antibiotics has occurred, with 28 of 35 countries lacking penicillin-type drugs.

In 2024, US drug shortages reached 323, exceeding the 2014 record of 320.

In 2024, US drug shortages reached 323, exceeding the 2014 record of 320.

In 2024, US drug shortages reached 323, exceeding the 2014 record of 320.

[7] Ireland suffered a paracetamol shortage in 2023 due to Covid-19 and flu cases, with medicine shortages increasing worldwide over the past decade.

A survey found 99% of hospital pharmacists report drug shortages, with 309 drugs affected, near an all-time high.

A survey found 99% of hospital pharmacists report drug shortages, with 309 drugs affected, near an all-time high.

A survey found 99% of hospital pharmacists report drug shortages, with 309 drugs affected, near an all-time high.

The US had 323 medical drug shortages in 2021, surpassing the previous record of 320 in 2014.

The US had 323 medical drug shortages in 2021, surpassing the previous record of 320 in 2014.

The US had 323 medical drug shortages in 2021, surpassing the previous record of 320 in 2014.

Amoxicillin is in short supply, with 66% of US pharmacies unable to obtain it due to supply chain issues.

Amoxicillin is in short supply, with 66% of US pharmacies unable to obtain it due to supply chain issues.

Amoxicillin is in short supply, with 66% of US pharmacies unable to obtain it due to supply chain issues.

The dollar crisis in Egypt has caused a shortage of medicines due to a lack of hard currency.

The dollar crisis in Egypt has caused a shortage of medicines due to a lack of hard currency.

The dollar crisis in Egypt has caused a shortage of medicines due to a lack of hard currency.

The coronavirus epidemic has caused drug shortages in Malaysia, worsened by a weak ringgit exchange rate.

The coronavirus epidemic has caused drug shortages in Malaysia, worsened by a weak ringgit exchange rate.

The coronavirus epidemic has caused drug shortages in Malaysia, worsened by a weak ringgit exchange rate.

The FDA has reported US drug shortages, including ADHD medications, and has allowed imports of some chemotherapy drugs.

The FDA has reported US drug shortages, including ADHD medications, and has allowed imports of some chemotherapy drugs.

The FDA has reported US drug shortages, including ADHD medications, and has allowed imports of some chemotherapy drugs.

The Ministry of Health has proposed a strategy to address medication shortages.

The Ministry of Health has proposed a strategy to address medication shortages.

The Ministry of Health has proposed a strategy to address medication shortages.

The FDA tracks drug shortages and provides real-time information on their website.

The FDA tracks drug shortages and provides real-time information on their website.

The FDA tracks drug shortages and provides real-time information on their website.

Patients have the right to know about medication shortages and participate in their healthcare.

Patients have the right to know about medication shortages and participate in their healthcare.

Adderall and liquid Amoxicillin are in short supply due to manufacturing issues and production delays, respectively.

Adderall and liquid Amoxicillin are in short supply due to manufacturing issues and production delays, respectively.

Adderall and liquid Amoxicillin are in short supply due to manufacturing issues and production delays, respectively.

The US prescription drug shortage list includes 250 medications, mostly generics that account for 90% of US prescriptions.

The US prescription drug shortage list includes 250 medications, mostly generics that account for 90% of US prescriptions.

The US prescription drug shortage list includes 250 medications, mostly generics that account for 90% of US prescriptions.

For patients with chronic pain, oral morphine is a slow-acting alternative to IV paracetamol.

For patients with chronic pain, oral morphine is a slow-acting alternative to IV paracetamol.

For patients with chronic pain, oral morphine is a slow-acting alternative to IV paracetamol.

Alternative medicines have the same effect as original medicines for patients with chronic conditions.

Alternative medicines have the same effect as original medicines for patients with chronic conditions.

Alternative medicines have the same effect as original medicines for patients with chronic conditions.

Cancer centers have reported shortages of key medications like carboplatin, cisplatin, and methotrexate, with 86% of centers experiencing anti-cancer drug shortages.

In Ireland, 216 medicines are unavailable, including most liquid antibiotics and dissolvable disprin.

In Ireland, 216 medicines are unavailable, including most liquid antibiotics and dissolvable disprin.

In Ireland, 216 medicines are unavailable, including most liquid antibiotics and dissolvable disprin.

Older drugs often face shortages after coming off patent due to reduced production.

Older drugs often face shortages after coming off patent due to reduced production.

Older drugs often face shortages after coming off patent due to reduced production.

A £5.3m support package is being finalized to help patients affected by shortages of osteoporosis and high blood pressure treatments.

A £5.3m support package is being finalized to help patients affected by shortages of osteoporosis and high blood pressure treatments.

A £5.3m support package is being finalized to help patients affected by shortages of osteoporosis and high blood pressure treatments.

Incident command centers and strategies like delaying elective exams can help hospitals respond to shortages.

Incident command centers and strategies like delaying elective exams can help hospitals respond to shortages.

Clinical pharmacists manage medication shortages by coordinating with medical teams and advising patients on safe and effective medicine use.

Taiwan's government has implemented a monitoring system to address medication shortages.

Taiwan's government has implemented a monitoring system to address medication shortages.

Taiwan's government has implemented a monitoring system to address medication shortages.

The University of Utah's Drug Information Service tracks drug shortages, providing valuable information for healthcare providers.

The University of Utah's Drug Information Service tracks drug shortages, providing valuable information for healthcare providers.

The University of Utah's Drug Information Service tracks drug shortages, providing valuable information for healthcare providers.

The FDA has set up a "Drug Supply Information Platform" to report and track medication shortages.

The FDA has set up a "Drug Supply Information Platform" to report and track medication shortages.

The FDA has set up a "Drug Supply Information Platform" to report and track medication shortages.

Patients with chronic diseases like motor neurone disease face challenges accessing medication due to stock shortages.

Patients with chronic diseases like motor neurone disease face challenges accessing medication due to stock shortages.

Patients with chronic diseases like motor neurone disease face challenges accessing medication due to stock shortages.

A shortage of essential drugs, including antibiotics and pediatric medications, is a growing concern, with eight out of 10 antibiotics unavailable in some regions.

In Egypt, the pharmaceutical market faces a severe shortage of various medications, including blood thinners, cancer treatments, and multiple sclerosis drugs.

Smart pill bottle technology and online portals monitor medication adherence and provide real-time patient data to pharmacies.

Smart pill bottle technology and online portals monitor medication adherence and provide real-time patient data to pharmacies.

Smart pill bottle technology and online portals monitor medication adherence and provide real-time patient data to pharmacies.

In Kenya, delays on the eCitizen portal have crippled health services and medication imports.

In Kenya, delays on the eCitizen portal have crippled health services and medication imports.

In Kenya, delays on the eCitizen portal have crippled health services and medication imports.

The FTC and US Health Department are investigating chemotherapy drug shortages reported by 93% of treatment centers.

The FTC and US Health Department are investigating chemotherapy drug shortages reported by 93% of treatment centers.

The FTC and US Health Department are investigating chemotherapy drug shortages reported by 93% of treatment centers.

The shortage of ADHD medications, including methylphenidate, has persisted for months, affecting patients of all ages.

The shortage of ADHD medications, including methylphenidate, has persisted for months, affecting patients of all ages.

The shortage of ADHD medications, including methylphenidate, has persisted for months, affecting patients of all ages.

The Tomny app provides real-time medication availability and allows user inquiries.

The Tomny app provides real-time medication availability and allows user inquiries.

The Tomny app provides real-time medication availability and allows user inquiries.

The CharmHealth platform offers real-time prescription benefits, electronic prescribing, and prescription price transparency.

The CharmHealth platform offers real-time prescription benefits, electronic prescribing, and prescription price transparency.

The CharmHealth platform offers real-time prescription benefits, electronic prescribing, and prescription price transparency.

The Samsung Health app offers a Medication Tracking feature with detailed medication information and interactions.

The Samsung Health app offers a Medication Tracking feature with detailed medication information and interactions.

The Affordable Medicines program offers 486 free drugs and free medicine appointments with e-prescriptions from family doctors.

The Affordable Medicines program offers 486 free drugs and free medicine appointments with e-prescriptions from family doctors.

The Affordable Medicines program offers 486 free drugs and free medicine appointments with e-prescriptions from family doctors.

In Odessa, vital medicines, including insulin, are available in pharmacies.

In Odessa, vital medicines, including insulin, are available in pharmacies.

In Odessa, vital medicines, including insulin, are available in pharmacies.

A mobile app shows medication availability, alternatives, pharmacy locations, and contact information.

A mobile app shows medication availability, alternatives, pharmacy locations, and contact information.

Patients can receive medications via electronic or paper prescription, and pharmacies can be filtered by medication availability.

Patients can receive medications via electronic or paper prescription, and pharmacies can be filtered by medication availability.

In cases of medicine shortages, patients can call the Poison Control Helpline or consult their primary care physician or pharmacist for alternative solutions.

CareConnect and Gray's Compounding Pharmacy offer healthcare information and medication reviews with patient permission.

CareConnect and Gray's Compounding Pharmacy offer healthcare information and medication reviews with patient permission.

Patients are sometimes sent home with alternative medications, like paracetamol, due to drug shortages.

Patients are sometimes sent home with alternative medications, like paracetamol, due to drug shortages.

Patients are sometimes sent home with alternative medications, like paracetamol, due to drug shortages.

For patients with chronic life-threatening conditions, support systems can help with medication access.

For patients with chronic life-threatening conditions, support systems can help with medication access.

The World Health Organization (WHO) supports healthcare and provides funding for life-saving treatments in countries like Syria.

The World Health Organization (WHO) supports healthcare and provides funding for life-saving treatments in countries like Syria.

The World Health Organization (WHO) supports healthcare and provides funding for life-saving treatments in countries like Syria.